Patheon Inc. (PTI.TO) Restructure Complete; New Company, DPx Expects $2 Billion In Annual Sales
3/11/2014 12:02:06 PM
Restructuring of the former Patheon Pharmaceuticals has been completed, and the pharmaceutical services company is now a business unit of DPx Holdings B.V. (DPx).
DPx is privately owned by JLL Partners and Royal DSM and launched as a global contract development and manufacturing organization (CDMO) for the pharmaceutical and related industries. DPx is the result of a $2.65 billion transaction between JLL Partners, a middle-market private equity firm, and Royal DSM, a Netherlands-based life sciences conglomerate.
Help employers find you! Check out all the jobs and post your resume.
comments powered by